期刊文献+

不同状态绝经后妇女激素替代疗法的个性化选择策略 被引量:2

Hormone Replacement Therapy should be Personalized
下载PDF
导出
摘要 激素替代疗法(HRT)是目前缓解绝经相关症状和预防绝经后骨质疏松等疾病最有效的方案。HRT治疗中要求遵循个性化原则,根据患者的不同症状、年龄和不同的基础疾病状况,有无HRT适应证和禁忌证,掌握慎用情况及不同药物的特点,选择最佳治疗窗,使用最低剂量从而达到最佳治疗效果。 Hormone replacement therapy (HRT) is of choice for menopause population, to alleviate effectively those symptoms of menopause and to prevent the postmenopausal osteoporosis. However, it is necessary that HRT be personalized. The principles of personalized HRT are based on many aspects, such as symptoms, age, baseline diseases, indications and contraindications. When HRT is prescribed, many other aspects should be considered, including preparation and dose of HRT drug, route of administration, and the best 'treatment window'. The HRT should start at minimum dose with the best effect of treatment.
作者 陈梅 郁琦
出处 《国际生殖健康/计划生育杂志》 CAS 2013年第5期352-355,共4页 Journal of International Reproductive Health/Family Planning
关键词 绝经期 激素替代疗法 骨质疏松 绝经后 个性 Menopause Hormone replacement therapy Osteoporosis, postmenopausal Individuality
  • 相关文献

参考文献19

  • 1Nelson HD,Walker M,Zakher B,et al. Menopausal hormone therapy for the primary prevention of chronic conditions:a systematic review to update the U.S. Preventive Services Task Force recommendations [J]. Ann Intern Med,2012,157(2):104-113.
  • 2Hodis HN,Mack WJ. The timing hypothesis and hormone replacement therapy:a paradigm shift in the primary prevention of coronary heart disease in women. Part 2:comparative risks [J]. J Am Geriatr Soc,2013,61(6): 1011-1018.
  • 3Canonico M,Plu-Bureau G,Scarabin PY. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy [J]. Maturitas, 2011,70(4) : 354-360.
  • 4Fichera M, Rinaldi N,Tarascio M, et al. Indications and controindications of hormone replacement therapy in menopause [J]. Minerva Ginecol,2013,65(3):331-344.
  • 5Mackay L,Kilbride L,Adamson KA,et al. Hormone replacement therapy for women with type 1 diabetes mellitus [J]. Cochrane Database Syst Rev, 2013,6 : CD008613.
  • 6Hart AR, Luben R, Welch A,et al. Hormone replacement therapy and symptomatic Gallstones-a prospective population study in the EPIC-Norfolk cohort [J]. Digestion ,2008,77( 1 ) :4-9.
  • 7link between oestrogen Dhiman RK,Chawla YK. Is there a Expert Opin Drug Saf, therapy and gallbladder disease? [J]. 2006,5( 1 ) : 117-129.
  • 8Campbell IA, Douglas JG, Francis RM,et al. Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial [J]. Scott Med J, 2009,54( 1 ):21-25.
  • 9Andersen L, Friis S, Hallas J, et al. Hormone replacement therapy increases the risk of cranial meningioma [J]. Eur J Cancer,2013, Jun 22. [Epub ahead of print].
  • 10Daayana S,Holland CM. Hormone replacement therapy and the endometrium [J]. Menopause Int,2009,15(3):134"138.

共引文献5

同被引文献8

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部